Nontuberculous Mycobacterial Pulmonary Disease

• CLINICAL_TRIALS trial_result · 2025-10-09
  Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for the Treatment of Participants With Mycobacterium Avium Complex (MAC) Pulmonary Disease [Phase 2]

  Phase 2 study evaluating SPR720 versus placebo for Nontuberculous Mycobacterial Pulmonary Disease, including MAC pulmonary disease, assessin…

• CLINICAL_TRIALS trial_result · 2025-07-30
  Clinical Trial Update: Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc) [Phase 2]

  A Phase 2 trial comparing oral omadacycline to placebo in adults with nontuberculous mycobacterial pulmonary disease caused by the Mycobacte…

• CLINICAL_TRIALS trial_result · 2024-07-08
  Clinical Trial Update: Exercise Intervention in Patients With Nontuberculous Mycobacterial Pulmonary Disease [NA]

  A completed clinical trial studying the effects of an exercise intervention in patients with nontuberculous mycobacterial pulmonary disease.

• CLINICAL_TRIALS trial_result · 2024-06-28
  Clinical Trial Update: Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex [Phase 3]

  Phase 3 trial update validating patient-reported outcome measures in participants with nontuberculous mycobacterial pulmonary disease caused…

• CLINICAL_TRIALS trial_result · 2006-08-23
  Clinical Trial Update: Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease [Phase 4]

  This Phase 4 trial compared clarithromycin to ciprofloxacin when added to rifampicin plus ethambutol for opportunistic mycobacterial pulmona…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.